5-Benzoylamino-1,3-dioxacyclanes, the method for preparing the same and their use as PKC inhibitor
申请人:Zen Hayley
公开号:US20050043396A1
公开(公告)日:2005-02-24
The present invention discloses a series of benzoylamino-1,3-dioxacyclane compounds, of which compounds 1-21 were prepared via transacetalisation reaction between N-benzoylaminoglycol and 1,1,3,3-tetramethoxypropane; while compounds 22-48 were prepared via stereospecific acetalisation reaction between N-benzoylamino glycol and aromatic aldehyde, and if necessary, the nitro groups were reduced and further be salified with propane diacid and L-Arg or L-Lys. These compounds possess the structural type of PKC inhibitor and positive anti-inflammatory effect, and can be applied in medical fields as PKC inhibitor for corresponding therapy.
本发明公开了一系列苯甲酰氨基-1,3-二氧杂环丁烷化合物,其中化合物1-21是通过N-苯甲酰氨基乙醇与1,1,3,3-四甲氧基丙烷之间的缩酮化反应制备的;而化合物22-48是通过N-苯甲酰氨基乙醇与芳香醛之间的立体特异性缩醛化反应制备的,如果有必要,可以将硝基还原,并进一步与丙烷二酸和L-精氨酸或L-赖氨酸成盐。这些化合物具有PKC抑制剂的结构类型和积极的抗炎效果,并且可以作为PKC抑制剂应用于医学领域的相应治疗。